DAVITA INC. DVA
NYSE · XNYS · stock · Services-Misc Health & Allied Services, NEC
Chart by TradingView
6/9
Piotroski F — financial health
1.04
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $13.6B | $746.8M | — | $1.3B | -$373.7M |
| 2024 | $12.8B | $936.3M | — | $1.5B | $121.1M |
| 2023 | $12.1B | $691.5M | — | $1.5B | $1.1B |
| 2022 | $11.6B | $560.4M | — | $961.1M | $712.3M |
| 2021 | $11.6B | $978.5M | — | $1.3B | $936.1M |
| 2020 | $11.6B | $773.6M | — | $1.3B | $1.6B |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.04 (distress)
- Working capital / assets 0.052
- Retained earnings / assets -0.019
- EBIT / assets 0.117
- Equity / liabilities -0.023
Source: SEC EDGAR filings · CIK 0000927066 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.